Clinical trials are scientific studies in which new treatments – drugs, diagnostic procedures, therapies, or preventive measures – are tested in patients to determine if they are safe and effective. Running successful clinical trials requires highly ethical, organized and experienced personnel. One such professional recently joined the University of Tennessee Health Science Center (UTHSC) in… Read More
Feb. 1st marks the 55th anniversary of James W. Pate, M.D. as an active faculty member of the College of Medicine. Dr. Pate has participated in many of the dramatic changes in UTCHS and in local and national teaching, training, research, and health care delivery. He still participates in student and resident conferences and lectures… Read More
Multiple sclerosis (MS) is a debilitating neurological disease that affects 2.3 million people worldwide, a number that has gone up 10 percent in the past five years.
CANDLE Study and the Neuroscience Institute at The University of Tennessee Health Science Center Partner with The Urban Child Institute for Brain Awareness Event Astronomer, astrophysicist and cosmologist Carl Sagan said, “The brain is like a muscle. When it is in use we feel very good. Understanding is joyous.” How we set the human brain on… Read More
A new guideline for the management of high blood pressure, developed by an expert panel and including nine recommendations and a treatment algorithm (flow chart) to help doctors treat patients with hypertension, was published online on December 18, 2013 by JAMA. Department of Veterans Affairs (VA) Barnwell Award Laureate, William C. Cushman, M.D., chief of… Read More
Jena J. Steinle, PhD, associate professor in the Departments of Ophthalmology, Anatomy and Neurobiology, and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been appointed director of research at the Hamilton Eye Institute.
Seriously ill patients who develop bacterial infections in the bloodstream require aggressive treatment with antibiotics. They also can develop kidney failure that requires hemodialysis.
In the United States, nearly 11 million caregivers provide 12.5 billion hours of care annually to those with Alzheimer’s disease, according to Linda Nichols, PhD, professor of Preventive Medicine and Internal Medicine at the University of Tennessee Health Science Center (UTHSC).
